arBtrage CAPITALIZING MARKETS checking… Sign in

Candel Therapeutics, Inc.

CADL Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$8.51
▼ -8.2% Today
as of Jun 7, 06:55 ET
Last 30 days +37.26% Apr 28 → Jun 05
$5.93 $6.83 $7.73 $8.62 $9.52 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$9.18
High
$9.23
Low
$8.34
Volume
$2M
Avg Vol
$1M
Mkt Cap
$593M
P/E (TTM)
Beta
52w High
$9.27
52w Low
$4.35
Div Yield
Shares Out
$73M

Overview

52-week range
$4.35
$9.27
85% of range
Avg surprise (last 2)
+95.3%
Avg reaction (last 2)
+3.7%
50% positive
Latest IV / EM
310%
EM ±42.9% · $9 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.74$-0.52$-0.30$-0.09$0.13 Actual $-0.33Actual $-0.29Actual $-0.28Actual $-0.74Actual $-0.33Actual $0.13Est $-0.24Actual $-0.09Actual $-0.21Actual $-0.14Est $-0.22 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-22M$-15M$-7M$251,712$8M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-0.14 $-0.22 +36.4% -207.7% -0.3% earnings
Tue Sep 30, 2025Sep 2025 $-0.21 financials
Mon Jun 30, 2025Jun 2025 $-0.09 financials
Tue May 13, 2025Mar/2025 $0.13 $-0.24 +154.2% +7.7% earnings
Mon Sep 30, 2024Sep 2024 $-0.33 financials
Sun Jun 30, 2024Jun 2024 $-0.74 financials
Sun Mar 31, 2024Mar 2024 $-0.28 financials
Sat Sep 30, 2023Sep 2023 $-0.29 financials
Fri Jun 30, 2023Jun 2023 $-0.33 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-16M$-13M$-11M$-8M$-9M$-9M
Net income$-9M$-11M$-5M$7M$-11M$-22M
EPS (diluted)$-0.14$-0.21$-0.09$0.13$-0.33$-0.74

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$195M$120M$87M$101M$92M$103M$17M$21M
Inventory
Total current assets$198M$121M$90M$104M$93M$104M$18M$23M
Total assets$202M$125M$94M$106M$96M$107M$22M$26M
Long-term debt$4M$7M
Total liabilities$64M$73M$13M$16M$21M$41M$37M$36M
Total equity$138M$52M$80M$90M$75M$66M$-15M$-10M

Implied volatility — last 90 days

304%307%309%312%314% Jun 07 — IV 310% · EM ±42.9%

Sector peers